YahooAugust 12, 2026 at 7:37 AM NY23 days ago

Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales

Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

TECHBio-Techne Corp72.43− 0.03%

Companies in This Story

Related Stories